BG
GBT

BlackRock Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History

BlackRock Group’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$2.69M Buy
186,405
+12,403
+7% +$218K ﹤0.01% 1566
2016
Q3 		$4.01M Sell
174,002
-1,070
-0.6% -$20.4K ﹤0.01% 1213
2016
Q2 		$2.9M Buy
175,072
+172,783
+7,548% +$3.49M ﹤0.01% 1339
2016
Q1 		$36K Buy
2,289
+1,197
+110% +$21.3K ﹤0.01% 2983
2015
Q4 		$35K Sell
1,092
-115,308
-99% -$4.99M ﹤0.01% 2873
2015
Q3 		$4.91M Buy
+116,400
New +$5.49M ﹤0.01% 1116

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BlackRock Group's GBT Position: Q4 2016 in Review

BlackRock Group increased its Global Blood Therapeutics, Inc. (GBT) stake by 7.1% in Q4 2016, buying an estimated $218K and bringing the position to 186,405 shares worth $2.69M. The position accounts for ﹤0.01% of the portfolio, ranked #1566.

BlackRock Group first reported a position in GBT in Q3 2015 and has held it in 6 quarters since. The position peaked at $4.91M in Q3 2015. 96 funds tracked by Wall St. Rank hold GBT as of Q4 2016.

  • BlackRock Group held 186,405 shares of Global Blood Therapeutics, Inc. worth $2.69M as of Q4 2016.
  • BlackRock Group bought 12,403 Global Blood Therapeutics, Inc. shares in Q4 2016, an estimated $218K.
  • Global Blood Therapeutics, Inc. made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #1566 holding.
  • BlackRock Group first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and has held it in 6 quarters since.
  • BlackRock Group's Global Blood Therapeutics, Inc. position peaked at $4.91M in Q3 2015.
  • 96 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.